Skip to main content
AHRAmerican Healthcare REIT, Inc.Sell5.7·$55.04+2.59%
SellModerate Confidence
Investment thesis

American Healthcare REIT delivers exceptional cash conversion and 21% revenue growth but quality sits just below the minimum acceptable floor and a single counterparty representing more than half the portfolio creates a binary concentration risk that dominates the investment case.

Thesis pillars

  • Above Peer Revenue GrowthStable
  • Exceptional Cash ConversionStable
  • Single Tenant Concentration RiskStable
  • +1 more pillar — see the Why tab for full reasoning

Full reasoning →

Open full analysis

American Healthcare REIT, Inc. (AHR) Stock Analysis

SellVALUE-TRAP 2/5Moderate Confidence

Real Estate · REIT - Healthcare Facilities

Sell if holding. Engine safety override at $55.04: a dimension score below its floor triggers a hard block regardless of the otherwise-positive setup — overall score 5.7/10. Specifically: Below-average business quality; Rich valuation.

American Healthcare REIT acquires, owns, and operates clinical healthcare real estate—primarily senior housing (ISHC/SHOP), skilled nursing facilities, and outpatient medical buildings—across the U.S., UK, and Isle of Man, employing approximately 121 people as of December 31,... Read more

$55.04-1.9% A.UpsideScore 5.7/10#5 of 16 REIT - Healthcare Facilities
QualityF-score7 / 9FCF yield3.38%
IncomeYield1.82%Payout169.49%
Stop $52.16Target $53.99(resistance)A.R:R -0.5:1
Analyst target$58.23+5.8%13 analysts
$53.99our TP
$55.04price
$58.23mean
$51
$67

Sell if holding. Engine safety override at $55.04: a dimension score below its floor triggers a hard block regardless of the otherwise-positive setup — overall score 5.7/10. Specifically: Below-average business quality; Rich valuation. Chart setup: No clear chart pattern; technical signals are mixed. Score 5.7/10, moderate confidence.

Passes 6/8 gates (positive momentum, clean insider activity, news events none recent, earnings proximity 33d clear, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio. Suitability: moderate.

10-K grounded · weekly refresh

About American Healthcare REIT, Inc.

About American Healthcare REIT, Inc.

American Healthcare REIT holds a portfolio spanning integrated senior health campuses (ISHC), senior housing operating properties (SHOP), skilled nursing facilities, and outpatient medical buildings across the United States, United Kingdom, and Isle of Man. The company raised $772.8 million through a February 2024 NYSE IPO under ticker "AHR" and employed approximately 121 staff at December 31, 2025. Trilogy Management Services manages all ISHC properties, which contributed 55.5% of annualized net operating income at year-end 2025, with the Trilogy-managed portfolio accounting for 45.3% of aggregate contract purchase price.

AHR earns revenue through two structures. At triple-net leased properties, tenants pay rent and bear operating expenses, with most leases expected to carry five-year-or-longer terms and renewal options. SHOP and ISHC properties operate under the RIDEA structure permitted by the REIT Investment Diversification and Empowerment Act of 2007, allowing the company's taxable REIT subsidiaries to engage third-party operators. Short-term resident leases at RIDEA properties—typically one year or less—allow operators to adjust rents with market conditions. Medicare and Medicaid reimbursement rates are a material input to operator economics; reimbursement rates that do not rise as quickly as the cost of providing services could adversely affect tenants' ability to make rental payments and AHR's profitability from RIDEA operations. On an opportunistic basis, AHR also holds secured mortgage and mezzanine loans as a secondary investment activity.

Show full overview

The reliance on Trilogy Management Services is the most specific concentration risk disclosed in the filing. The company states that replacing Trilogy would require approval from applicable regulatory authorities and one or more mortgage lenders, and that any transition would likely disrupt staffing, financial reporting, and operations. If Trilogy experiences financial, legal, or accounting difficulties—including potential acceleration of indebtedness or insolvency proceedings—the impact would fall directly on management of AHR's largest NOI-producing segment, an outcome the 10-K characterizes as potentially having a material adverse effect.

See also: Real Estate · REIT - Healthcare Facilities

From American Healthcare REIT, Inc.'s most recent 10-K filing, extracted June 9, 2026.

news + 30-day 8-K events · 5-min refresh

Recent developments

updated 2026-07-06

Recent Developments — American Healthcare REIT, Inc.

Generated 2026-07-06T04:40:26Z.

TrendMatrix Research · upcoming catalyst calendar

Upcoming dated catalysts

Thu, Aug 6, 202633d to earnings· next earnings call

Thesis

Rewards
No bull case signals
Risks
Concentration risk — Counterparty: Trilogy Manager (55.5%)
Target reached (-8.0% upside)
Quality below floor (3.9 < 4.0)

Key Metrics

P/E (TTM)93.3
P/E (Fwd)64.0
Mkt Cap$10.6B
EV/EBITDA29.4
Profit Mgn4.2%
ROE3.5%
Rev Growth20.9%
Beta0.78
Dividend1.82%
Rating analysts10

Quality Signals

Piotroski F7/9MoatNarrow

Options Flow

P/C1.18bearish
IV64%elevated

Concentration Risks(10-K Item 1A)

  • HIGHcounterpartyTrilogy Manager56%
    10-K Item 1A: 'The Trilogy Manager manages all of the day-to-day operations for all of our ISHC ... contributed approximately 55.5% of our annualized base rent/annualized net operating income, or NOI'

Material Events(8-K, last 90d)

  • 2026-03-24Item 5.02LOW
    8-K/A amending Feb 4, 2026 filing. Jeffrey T. Hanson (Interim CEO/Chairman) entered compensation agreement retroactive to Feb 4, 2026: base salary $70,666.67/month, 120% target annual bonus pro-rated for service period. Prosky remains on medical leave; no return timeline disclosed.
    SEC filing →

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Rating Breakdown

3 floor-breakers·1 ceiling hit

Technicals below the gate floor. Component breakdown shows what dragged the score down.static

Bollinger
0.0
Support Resistance
0.0
52w Position
10.0

Priced at a premium — multiples above sector norms. Needs delivery on growth + margins to justify.static

Ev Ebitda
0.0
P Ocf
3.2
Analyst Target
4.0
Ps
7.3
P/OCF: 33.7x (FFO proxy — REITs gated off P/E)

Quality below the gate floor. Component breakdown shows what dragged the score down.static

Gross Margin
0.0
Roe
1.2
Roa
1.4
Net Margin
2.1
Operating Margin
2.6
Current Ratio
4.0
Moat
5.6
Piotroski F
7.8
Fcf Quality
10.0
Excellent cash conversion: 357% FCF/NIStrong Piotroski F-Score: 7/9
GatesA.R:R -0.5=NEGATIVEExecutive change: officer departure/appointmentMomentum 7.2>=5.5Insider activity: OKNEWS EVENTS NONE RECENTEARNINGS PROXIMITY 33d clearSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARSuitability: Moderate
RSI
93 · Overbought
20D MA 50D MA 200D MAGOLDEN CROSSSupport $44.59Resistance $55.09

Price Targets

$52
$54
A.Upside-1.9%
A.R:R-0.5:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeSteady

Risk Alerts

! Target reached (-8.0% upside)
! Quality below floor (3.9 < 4.0)
! Value-trap signals (2/5): High leverage (D/E 1.8), Negative free cash flow

Earnings

B
B
M
M
2/4 beats
Next Earnings2026-08-06 (33d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is AHR stock a buy right now?

Sell if holding. Engine safety override at $55.04: a dimension score below its floor triggers a hard block regardless of the otherwise-positive setup — overall score 5.7/10. Specifically: Below-average business quality; Rich valuation. Chart setup: No clear chart pattern; technical signals are mixed. Prior stop was $52.16. Score 5.7/10, moderate confidence.

What is the AHR stock price target?

Take-profit target: $53.99 (-1.9% upside). Prior stop was $52.16. Stop-loss: $52.16.

What are the risks of investing in AHR?

Concentration risk — Counterparty: Trilogy Manager (55.5%); Target reached (-8.0% upside); Quality below floor (3.9 < 4.0).

Is AHR overvalued or undervalued?

American Healthcare REIT, Inc. trades at a P/E of 93.3 (forward 64.0). TrendMatrix value score: 3.8/10. Verdict: Sell.

What do analysts say about AHR?

10 analysts cover AHR with a consensus score of 4.0/5. Average price target: $58.

What does American Healthcare REIT, Inc. do?American Healthcare REIT acquires, owns, and operates clinical healthcare real estate—primarily senior housing...

American Healthcare REIT acquires, owns, and operates clinical healthcare real estate—primarily senior housing (ISHC/SHOP), skilled nursing facilities, and outpatient medical buildings—across the U.S., UK, and Isle of Man, employing approximately 121 people as of December 31, 2025. Revenue flows from triple-net leases and RIDEA-structured operations, with all integrated senior health campuses managed by Trilogy Management Services, which contributed approximately 55.5% of annualized NOI at year-end 2025.

Related stocks: OHI (Omega Healthcare Investors, Inc) · SBRA (Sabra Health Care REIT, Inc.) · MPT (Medical Properties Trust, Inc.) · VTR (Ventas, Inc.) · DOC (Healthpeak Properties, Inc.)
Home Stocks AHR

Latest news

Latest News

Benzinga13d agoAnalyst
Benzinga13d agoAnalyst
Benzinga18d ago
Benzinga39d agoAnalyst
Benzinga41d ago
Benzinga46d ago
Benzinga46d ago
Benzinga59d agoEarnings
Benzinga59d agoEarnings